LayerRx Mapping ID
508
Slot System
Featured Buckets
Featured Buckets Admin
Medscape Lead Concept
56

Review of Intravascular Lymphoma With a Report of Treatment With Allogenic Peripheral Blood Stem Cell Transplant

Article Type
Changed
Display Headline
Review of Intravascular Lymphoma With a Report of Treatment With Allogenic Peripheral Blood Stem Cell Transplant

Article PDF
Author and Disclosure Information

Adam DN, Beleznay KM, Randhawa RS, Marton M, Zhou Y

Issue
Cutis - 82(4)
Publications
Topics
Page Number
267-272
Author and Disclosure Information

Adam DN, Beleznay KM, Randhawa RS, Marton M, Zhou Y

Author and Disclosure Information

Adam DN, Beleznay KM, Randhawa RS, Marton M, Zhou Y

Article PDF
Article PDF

Issue
Cutis - 82(4)
Issue
Cutis - 82(4)
Page Number
267-272
Page Number
267-272
Publications
Publications
Topics
Article Type
Display Headline
Review of Intravascular Lymphoma With a Report of Treatment With Allogenic Peripheral Blood Stem Cell Transplant
Display Headline
Review of Intravascular Lymphoma With a Report of Treatment With Allogenic Peripheral Blood Stem Cell Transplant
Article Source

PURLs Copyright

Inside the Article

Article PDF Media

Multicentric Reticulohistiocytosis Associated With Burkitt Lymphoma and Adenocarcinoma

Article Type
Changed
Display Headline
Multicentric Reticulohistiocytosis Associated With Burkitt Lymphoma and Adenocarcinoma

Article PDF
Author and Disclosure Information

Issue
Cutis - 82(2)
Publications
Topics
Page Number
113-114
Author and Disclosure Information

Author and Disclosure Information

Article PDF
Article PDF

Issue
Cutis - 82(2)
Issue
Cutis - 82(2)
Page Number
113-114
Page Number
113-114
Publications
Publications
Topics
Article Type
Display Headline
Multicentric Reticulohistiocytosis Associated With Burkitt Lymphoma and Adenocarcinoma
Display Headline
Multicentric Reticulohistiocytosis Associated With Burkitt Lymphoma and Adenocarcinoma
Article Source

PURLs Copyright

Inside the Article

Article PDF Media

Treatment of Nodular Basal Cell Carcinoma With 5-Aminolevulinic Acid Activated With a 595-nm Long-Pulsed Dye Laser: A Case Report

Article Type
Changed
Display Headline
Treatment of Nodular Basal Cell Carcinoma With 5-Aminolevulinic Acid Activated With a 595-nm Long-Pulsed Dye Laser: A Case Report

Article PDF
Author and Disclosure Information

Goldman MP, Szeimies R

Issue
Cutis - 82(1)
Publications
Topics
Page Number
404-408
Sections
Author and Disclosure Information

Goldman MP, Szeimies R

Author and Disclosure Information

Goldman MP, Szeimies R

Article PDF
Article PDF

Issue
Cutis - 82(1)
Issue
Cutis - 82(1)
Page Number
404-408
Page Number
404-408
Publications
Publications
Topics
Article Type
Display Headline
Treatment of Nodular Basal Cell Carcinoma With 5-Aminolevulinic Acid Activated With a 595-nm Long-Pulsed Dye Laser: A Case Report
Display Headline
Treatment of Nodular Basal Cell Carcinoma With 5-Aminolevulinic Acid Activated With a 595-nm Long-Pulsed Dye Laser: A Case Report
Sections
Article Source

Citation Override
Originally published in Cosmetic Dermatology
PURLs Copyright

Inside the Article

Article PDF Media

One-Week Treatment With Once-Daily Fluorouracil Cream 0.5% in Participants With Actinic Keratoses

Article Type
Changed
Display Headline
One-Week Treatment With Once-Daily Fluorouracil Cream 0.5% in Participants With Actinic Keratoses

Article PDF
Author and Disclosure Information

Menter A, Vamvakias G, Jorizzo J

Issue
Cutis - 81(6)
Publications
Topics
Page Number
509-516
Sections
Author and Disclosure Information

Menter A, Vamvakias G, Jorizzo J

Author and Disclosure Information

Menter A, Vamvakias G, Jorizzo J

Article PDF
Article PDF

Issue
Cutis - 81(6)
Issue
Cutis - 81(6)
Page Number
509-516
Page Number
509-516
Publications
Publications
Topics
Article Type
Display Headline
One-Week Treatment With Once-Daily Fluorouracil Cream 0.5% in Participants With Actinic Keratoses
Display Headline
One-Week Treatment With Once-Daily Fluorouracil Cream 0.5% in Participants With Actinic Keratoses
Sections
Article Source

PURLs Copyright

Inside the Article

Article PDF Media

Angiosarcoma Complicating Systemic Sclerosis: A Case Report

Article Type
Changed
Display Headline
Angiosarcoma Complicating Systemic Sclerosis: A Case Report

Angiosarcoma is a rare malignant vascular tumor that is localized to the skin or superficial soft tissue in 60% of cases.1,2 More than half of cutaneous angiosarcomas arise on the head or neck.2,3 Skin lesions may be difficult to diagnose early because of their highly variable and often seemingly innocuous appearance1-4; it is not uncommon for there to be extensive local spread and/or distant metastases by the time angiosarcoma is diagnosed. Cutaneous angiosarcoma typically affects elderly patients and is more common in men.1-4 It is relatively rare in black individuals.1,3 Classic presentation is an erythematous or violaceous lesion arising on the scalp of an elderly white man.1-4 Cutaneous angiosarcoma has well-documented associations with a number of conditions and factors, including chronic lymphedema, prior radiation therapy, and exposure to chemicals such as thorotrast and vinyl chloride.1-4 In addition, there are several reported cases of malignant transformation to angiosarcoma of otherwise benign vascular lesions such as hemangiomas.5 To date, there is only one reported case of cutaneous angiosarcoma arising in association with scleroderma on the face of a 77-year-old white woman with systemic sclerosis (SSc).6 We report the case of a 40-year-old black man with SSc who developed a cutaneous angiosarcoma in an area of sclerodermatous scalp. back to top


Case Report
A 40-year-old black man with a 5-year history of SSc involving the skin, lungs, and esophagus developed a painful nodule in a sclerodermatous plaque on the scalp (Figure 1). The patient's medical history was remarkable for Raynaud phenomenon, with recurrent digital ulcerations, a restrictive ventilatory defect, chronic dysphagia, and gastroesophageal reflux disease, as well as diffuse thickening and tightening of the skin, all related to his SSc. Serologic tests revealed antinuclear antibodies (titer ≥640) with a homogeneous nucleolar pattern and high levels of anti–Scl-70 antibodies. Anticentromere and anti-DNA antibodies were absent. His only medications were esomeprazole magnesium (40 mg daily) and amlodipine besylate (5 mg daily).

On physical examination, there was a 1.8-cm faintly erythematous nodule with overlying excoriations and crust on the right anterior parietal scalp. The remainder of the physical examination was notable for diffusely tight, firm, shiny skin involving the scalp, face, neck, chest, arms, hands, and groin. There were areas of depigmentation in several of the scleroderma plaques as well as multiple fingertip ulcerations. On initial evaluation, the scalp lesion was diagnosed as a skin abscess not requiring further intervention. It continued to grow and cause discomfort, eventually necessitating surgical excision. Because of its anatomic position and the extremely taut nature of the surrounding sclerodermatous scalp, the mass was excised only partially so that primary closure would be possible. Histologic evaluation of the 2.5X1.5-cm surgical specimen revealed an epithelioid-type high-grade angiosarcoma composed of cells that were positive for CD31 and CD34 (endothelial cell markers) on immunohistochemical stain (Figure 2). A wide excision of the lesion was then performed. Intraoperatively, the tumor was observed to have involved the galea and pericranium, necessitating removal of full-thickness soft tissue and adjacent bone (Figure 3). The scalp excision defect was closed with a split-thickness skin graft.

 Microscopic examination of the excised tissue revealed extensive invasion of the dermis, perineural tissue, and deep skeletal muscle by angiosarcoma. Both circumferential and deep margins of the surgical specimen were involved by tumor. Tumor size was estimated at 9.5 cm. Computed tomographic (CT) scans of the chest, abdomen, and pelvis revealed a moderately dilated esophagus and moderate diffuse, hazy, ground glass pattern radiodensities of the bilateral lung bases consistent with SSc but no lesions suggestive of metastasis. The extensive local tissue involvement by tumor dictated radiation therapy to the area. Treatment was delayed, however, by failure of the skin graft to completely heal. The open wound was subsequently surgically debrided and closed with an allograft. This second graft began to successfully heal, but an enlarging subcutaneous mass at its anterior border soon developed. Results of a biopsy revealed recurrent angiosarcoma. This lesion grew quickly to encompass over half of the patient's forehead, as well as the nasal root, causing severe periorbital edema and conjunctival congestion. Daily radiation therapy totaling 5000 cGy to the upper face and frontal, parietal, and occipital scalp was initiated. Soon after, the patient was hospitalized for methicillin-resistant Staphylococcus aureus bacteremia thought to have originated from a skin infection near the tumor. He also complained of worsening sharp right retroauricular and left hip pains. Results of a punch biopsy of the right posterior auricular scalp revealed recurrent angiosarcoma, and a CT-guided biopsy specimen of the left iliac bone revealed metastatic angiosarcoma. Magnetic resonance imaging of the pelvis and lower extremities showed bone marrow lesions involving the left ischium, left anterior superior iliac spine, and femoral necks of both legs. Palliative radiation therapy to the left iliac bone was initiated for symptom control. Given the extensive metastatic spread, systemic paclitaxel chemotherapy (100 mg/m2 weekly [3 of 4 weeks]) was administered through a central venous port. Soon after completing the first round of chemotherapy, the patient was hospitalized with a polymicrobial infection of his partially healed scalp wound including Klebsiella pneumoniae, Pseudomonas aeruginosa, and group B streptococci. He was treated with levofloxacin (500 mg daily for 10 days). An abdominal CT scan showed that the patient had a lesion in the right posterior inferior lobe of the liver suggestive of metastatic angiosarcoma. Several weeks after discharge, he presented to the emergency department of an outside hospital complaining of worsening dysphagia and purulent material draining from his central venous port. Shortly thereafter, he died, with sepsis as the presumed cause of death. At autopsy, there were multiple large scalp ulcerations extending to bone. The skin was diffusely firm and taut. Serial sectioning of the liver demonstrated a somewhat hemorrhagic-appearing dark red–brown lesion measuring 3 cm in the right posterior lobe, composed microscopically of diffusely infiltrating metastatic angiosarcoma confirmed by CD31 immunostain. Additionally, there were multifocal microabscesses of the heart, lungs, kidneys, spleen, and skin of the face and neck. 


Comment
Systemic sclerosis, or scleroderma, is a chronic systemic disease characterized by widespread fibrosis of the skin and internal organs, vasculopathy, and autoimmunity.7,8 Black individuals are affected more frequently than white individuals and tend to have an earlier age of disease onset, greater tendency for severe disease, and overall worse prognosis.9 Patients with SSc have a 2.6% to 8.7% risk of malignancy in general, with lung cancer and squamous cell carcinoma (arising in affected pulmonary or skin tissue) among the most commonly associated neoplasms.10,11 To our knowledge, we describe the second reported case of SSc-associated angiosarcoma. Systemic sclerosis is thought to arise from altered endothelial cell function and blood vessel reactivity occurring in association with inflammation and autoimmunity. The earliest disease manifestations are generally vasculature related, with most patients developing Raynaud phenomenon before manifesting signs and symptoms of overt sclerosis.7,8 Characteristic nail fold capillaroscopy findings in patients with SSc include enlarged capillaries, busy capillary formations, microhemorrhages, and variable capillary loss.7 Patients with SSc have increased serum and skin levels of vascular endothelial growth factor (VEGF), a key mediator of angiogenesis that induces differentiation, proliferation, and migration of endothelial cells.7 Endothelial cell VEGF receptors are up-regulated in SSc as well. This chronic overexpression of VEGF is thought to account for the chaotic vessel morphology observed on nail fold capillaroscopy.7 We hypothesize that elevated levels of VEGF in sclerodermatous skin may also predispose one to the development of angiosarcoma. Studies have shown that the proliferating cells in angiosarcoma overexpress VEGF messenger RNA, VEGF protein, and VEGF receptors, suggesting that VEGF may spur the development and invasion of neoplasia.12-14 Furthermore, Arbiser et al13 found that overexpression of human VEGF in immortalized endothelial cells was sufficient to convert them from benign hemangiomas to malignant angiosarcomas. Cutaneous angiosarcoma can assume a variety of clinical appearances, including bruiselike lesions, dusky plaques, chronic edema or cellulitis, ulcerated nodules, infectious-appearing lesions, and scarring alopecia.1-4 Tumor tissue usually extends far beyond the apparent borders of the lesion and frequently invades underlying soft tissue and bone. Thus, patients often have advanced disease at the time of diagnosis.1-4 Angiosarcoma prognosis is generally poor, with reported 5-year survival rates ranging from 10% to 35%.1,2 Surgical excision, extended-field radiotherapy, and/or paclitaxel chemotherapy are commonly employed modes of treatment,1,4,15,16 though even with these interventions, local tumor recurrence and distant metastases are common. Importantly, early diagnosis positively correlates with prolonged survival.3,4


Conclusion
We present a case of cutaneous angiosarcoma arising in an area of SSc-affected skin. We suspect that the co-occurrence of these 2 diseases may be related to interconnected underlying pathophysiology. Because early diagnosis can positively impact prognosis, physicians should maintain a high index of clinical suspicion and low threshold for performing a biopsy when suspicious lesions are present on sclerodermatous skin.

 

 

Acknowledgment—We thank Frederick M. Wigley, MD, for his detailed clinic and procedure notes. 

References

  1. Mark RJ, Poen JC, Tran LM, et al. Angiosarcoma: a report of 67 patients and a review of the literature. Cancer. 1996;77:2400-2406.
  2. Morgan MB, Swann M, Somach S, et al. Cutaneous angiosarcoma: a case series with prognostic correlation. J Am Acad Dermatol. 2004;50:867-874.
  3. Holden CA, Spittle MF, Jones EW. Angiosarcoma of the face and scalp, prognosis and treatment. Cancer. 1987;59:1046-1057.
  4. Haustein UF. Angiosarcoma of the face and scalp. Int J Dermatol. 1991;30:851-856.
  5. Rossi S, Fletcher CD. Angiosarcoma arising in hemangioma/vascular malformation: report of four cases and review of the literature. Am J Surg Pathol. 2002;26:1319-1329.
  6. Puizina-Ivic N, Bezic J, Marasovic D, et al. Angiosarcoma arising in sclerodermatous skin. Acta Dermatovenerol Alp Panonica Adriat. 2005;14:20-25.
  7. Distler O, Distler JH, Scheid A, et al. Uncontrolled expression of vascular endothelial growth factor and its receptors leads to insufficient skin angiogenesis in patients with systemic sclerosis. Circ Res. 2004;95: 109-116.
  8. Abraham DJ, Varga J. Scleroderma: from cell and molecular mechanisms to disease models. Trends Immunol. 2005;26:587-595.
  9. Reveille JD. Ethnicity and race and systemic sclerosis: how it affects susceptibility, severity, antibody genetics, and clinical manifestations. Curr Rheumatol Rep. 2003;5:160-167.
  10. Leandro MJ, Isenberg DA. Rheumatic diseases and malignancy—is there an association? Scand J Rheumatol. 2001;30:185-188.
  11. Rosenthal AK, McLaughlin JK, Gridley G, et al. Incidence of cancer among patients with systemic sclerosis. Cancer. 1995;76:910-914.
  12. Amo Y, Masuzawa M, Hamada Y, et al. Serum concentrations of vascular endothelial growth factor in angiosarcomas with and without p53 gene mutation. Acta Derm Venereol. 2002;82:373-374.
  13. Arbiser JL, Larsson H, Claesson-Welsh L, et al. Overexpression of VEGF 121 in immortalized endothelial cells causes conversion to slowly growing angiosarcoma and high level expression of the VEGF receptors VEGFR-1 and VEGFR-2 in vivo. Am J Pathol. 2000;156:1469-1476.
  14. Zietz C, Rössle M, Haas C, et al. MDM-2 oncoprotein overexpression, p53 gene mutation, and VEGF up-regulation in angiosarcomas. Am J Pathol. 1998;153:1425-1433.
  15. Fata F, O'Reilly E, Ilson D, et al. Paclitaxel in the treatment of patients with angiosarcoma of the scalp or face. Cancer. 1999;86:2034-2037.
  16. Skubitz KM, Haddad PA. Paclitaxel and pegylated-liposomal doxorubicin are both active in angiosarcoma. Cancer. 2005;104:361-366.
Article PDF
Author and Disclosure Information

Drs. Fonder and Douglas report no conflict of interest. The authors report no discussion of off-label use. Dr. Fonder is an intern in internal medicine, Greater Baltimore Medical Center, Maryland. Dr. Douglas is former Assistant Professor, Johns Hopkins Bayview Medical Center, Baltimore.

Margaret A. Fonder, MD; Deborah K. Douglas, MD

Issue
Cutis - 81(6)
Publications
Topics
Page Number
468-471
Author and Disclosure Information

Drs. Fonder and Douglas report no conflict of interest. The authors report no discussion of off-label use. Dr. Fonder is an intern in internal medicine, Greater Baltimore Medical Center, Maryland. Dr. Douglas is former Assistant Professor, Johns Hopkins Bayview Medical Center, Baltimore.

Margaret A. Fonder, MD; Deborah K. Douglas, MD

Author and Disclosure Information

Drs. Fonder and Douglas report no conflict of interest. The authors report no discussion of off-label use. Dr. Fonder is an intern in internal medicine, Greater Baltimore Medical Center, Maryland. Dr. Douglas is former Assistant Professor, Johns Hopkins Bayview Medical Center, Baltimore.

Margaret A. Fonder, MD; Deborah K. Douglas, MD

Article PDF
Article PDF

Angiosarcoma is a rare malignant vascular tumor that is localized to the skin or superficial soft tissue in 60% of cases.1,2 More than half of cutaneous angiosarcomas arise on the head or neck.2,3 Skin lesions may be difficult to diagnose early because of their highly variable and often seemingly innocuous appearance1-4; it is not uncommon for there to be extensive local spread and/or distant metastases by the time angiosarcoma is diagnosed. Cutaneous angiosarcoma typically affects elderly patients and is more common in men.1-4 It is relatively rare in black individuals.1,3 Classic presentation is an erythematous or violaceous lesion arising on the scalp of an elderly white man.1-4 Cutaneous angiosarcoma has well-documented associations with a number of conditions and factors, including chronic lymphedema, prior radiation therapy, and exposure to chemicals such as thorotrast and vinyl chloride.1-4 In addition, there are several reported cases of malignant transformation to angiosarcoma of otherwise benign vascular lesions such as hemangiomas.5 To date, there is only one reported case of cutaneous angiosarcoma arising in association with scleroderma on the face of a 77-year-old white woman with systemic sclerosis (SSc).6 We report the case of a 40-year-old black man with SSc who developed a cutaneous angiosarcoma in an area of sclerodermatous scalp. back to top


Case Report
A 40-year-old black man with a 5-year history of SSc involving the skin, lungs, and esophagus developed a painful nodule in a sclerodermatous plaque on the scalp (Figure 1). The patient's medical history was remarkable for Raynaud phenomenon, with recurrent digital ulcerations, a restrictive ventilatory defect, chronic dysphagia, and gastroesophageal reflux disease, as well as diffuse thickening and tightening of the skin, all related to his SSc. Serologic tests revealed antinuclear antibodies (titer ≥640) with a homogeneous nucleolar pattern and high levels of anti–Scl-70 antibodies. Anticentromere and anti-DNA antibodies were absent. His only medications were esomeprazole magnesium (40 mg daily) and amlodipine besylate (5 mg daily).

On physical examination, there was a 1.8-cm faintly erythematous nodule with overlying excoriations and crust on the right anterior parietal scalp. The remainder of the physical examination was notable for diffusely tight, firm, shiny skin involving the scalp, face, neck, chest, arms, hands, and groin. There were areas of depigmentation in several of the scleroderma plaques as well as multiple fingertip ulcerations. On initial evaluation, the scalp lesion was diagnosed as a skin abscess not requiring further intervention. It continued to grow and cause discomfort, eventually necessitating surgical excision. Because of its anatomic position and the extremely taut nature of the surrounding sclerodermatous scalp, the mass was excised only partially so that primary closure would be possible. Histologic evaluation of the 2.5X1.5-cm surgical specimen revealed an epithelioid-type high-grade angiosarcoma composed of cells that were positive for CD31 and CD34 (endothelial cell markers) on immunohistochemical stain (Figure 2). A wide excision of the lesion was then performed. Intraoperatively, the tumor was observed to have involved the galea and pericranium, necessitating removal of full-thickness soft tissue and adjacent bone (Figure 3). The scalp excision defect was closed with a split-thickness skin graft.

 Microscopic examination of the excised tissue revealed extensive invasion of the dermis, perineural tissue, and deep skeletal muscle by angiosarcoma. Both circumferential and deep margins of the surgical specimen were involved by tumor. Tumor size was estimated at 9.5 cm. Computed tomographic (CT) scans of the chest, abdomen, and pelvis revealed a moderately dilated esophagus and moderate diffuse, hazy, ground glass pattern radiodensities of the bilateral lung bases consistent with SSc but no lesions suggestive of metastasis. The extensive local tissue involvement by tumor dictated radiation therapy to the area. Treatment was delayed, however, by failure of the skin graft to completely heal. The open wound was subsequently surgically debrided and closed with an allograft. This second graft began to successfully heal, but an enlarging subcutaneous mass at its anterior border soon developed. Results of a biopsy revealed recurrent angiosarcoma. This lesion grew quickly to encompass over half of the patient's forehead, as well as the nasal root, causing severe periorbital edema and conjunctival congestion. Daily radiation therapy totaling 5000 cGy to the upper face and frontal, parietal, and occipital scalp was initiated. Soon after, the patient was hospitalized for methicillin-resistant Staphylococcus aureus bacteremia thought to have originated from a skin infection near the tumor. He also complained of worsening sharp right retroauricular and left hip pains. Results of a punch biopsy of the right posterior auricular scalp revealed recurrent angiosarcoma, and a CT-guided biopsy specimen of the left iliac bone revealed metastatic angiosarcoma. Magnetic resonance imaging of the pelvis and lower extremities showed bone marrow lesions involving the left ischium, left anterior superior iliac spine, and femoral necks of both legs. Palliative radiation therapy to the left iliac bone was initiated for symptom control. Given the extensive metastatic spread, systemic paclitaxel chemotherapy (100 mg/m2 weekly [3 of 4 weeks]) was administered through a central venous port. Soon after completing the first round of chemotherapy, the patient was hospitalized with a polymicrobial infection of his partially healed scalp wound including Klebsiella pneumoniae, Pseudomonas aeruginosa, and group B streptococci. He was treated with levofloxacin (500 mg daily for 10 days). An abdominal CT scan showed that the patient had a lesion in the right posterior inferior lobe of the liver suggestive of metastatic angiosarcoma. Several weeks after discharge, he presented to the emergency department of an outside hospital complaining of worsening dysphagia and purulent material draining from his central venous port. Shortly thereafter, he died, with sepsis as the presumed cause of death. At autopsy, there were multiple large scalp ulcerations extending to bone. The skin was diffusely firm and taut. Serial sectioning of the liver demonstrated a somewhat hemorrhagic-appearing dark red–brown lesion measuring 3 cm in the right posterior lobe, composed microscopically of diffusely infiltrating metastatic angiosarcoma confirmed by CD31 immunostain. Additionally, there were multifocal microabscesses of the heart, lungs, kidneys, spleen, and skin of the face and neck. 


Comment
Systemic sclerosis, or scleroderma, is a chronic systemic disease characterized by widespread fibrosis of the skin and internal organs, vasculopathy, and autoimmunity.7,8 Black individuals are affected more frequently than white individuals and tend to have an earlier age of disease onset, greater tendency for severe disease, and overall worse prognosis.9 Patients with SSc have a 2.6% to 8.7% risk of malignancy in general, with lung cancer and squamous cell carcinoma (arising in affected pulmonary or skin tissue) among the most commonly associated neoplasms.10,11 To our knowledge, we describe the second reported case of SSc-associated angiosarcoma. Systemic sclerosis is thought to arise from altered endothelial cell function and blood vessel reactivity occurring in association with inflammation and autoimmunity. The earliest disease manifestations are generally vasculature related, with most patients developing Raynaud phenomenon before manifesting signs and symptoms of overt sclerosis.7,8 Characteristic nail fold capillaroscopy findings in patients with SSc include enlarged capillaries, busy capillary formations, microhemorrhages, and variable capillary loss.7 Patients with SSc have increased serum and skin levels of vascular endothelial growth factor (VEGF), a key mediator of angiogenesis that induces differentiation, proliferation, and migration of endothelial cells.7 Endothelial cell VEGF receptors are up-regulated in SSc as well. This chronic overexpression of VEGF is thought to account for the chaotic vessel morphology observed on nail fold capillaroscopy.7 We hypothesize that elevated levels of VEGF in sclerodermatous skin may also predispose one to the development of angiosarcoma. Studies have shown that the proliferating cells in angiosarcoma overexpress VEGF messenger RNA, VEGF protein, and VEGF receptors, suggesting that VEGF may spur the development and invasion of neoplasia.12-14 Furthermore, Arbiser et al13 found that overexpression of human VEGF in immortalized endothelial cells was sufficient to convert them from benign hemangiomas to malignant angiosarcomas. Cutaneous angiosarcoma can assume a variety of clinical appearances, including bruiselike lesions, dusky plaques, chronic edema or cellulitis, ulcerated nodules, infectious-appearing lesions, and scarring alopecia.1-4 Tumor tissue usually extends far beyond the apparent borders of the lesion and frequently invades underlying soft tissue and bone. Thus, patients often have advanced disease at the time of diagnosis.1-4 Angiosarcoma prognosis is generally poor, with reported 5-year survival rates ranging from 10% to 35%.1,2 Surgical excision, extended-field radiotherapy, and/or paclitaxel chemotherapy are commonly employed modes of treatment,1,4,15,16 though even with these interventions, local tumor recurrence and distant metastases are common. Importantly, early diagnosis positively correlates with prolonged survival.3,4


Conclusion
We present a case of cutaneous angiosarcoma arising in an area of SSc-affected skin. We suspect that the co-occurrence of these 2 diseases may be related to interconnected underlying pathophysiology. Because early diagnosis can positively impact prognosis, physicians should maintain a high index of clinical suspicion and low threshold for performing a biopsy when suspicious lesions are present on sclerodermatous skin.

 

 

Acknowledgment—We thank Frederick M. Wigley, MD, for his detailed clinic and procedure notes. 

Angiosarcoma is a rare malignant vascular tumor that is localized to the skin or superficial soft tissue in 60% of cases.1,2 More than half of cutaneous angiosarcomas arise on the head or neck.2,3 Skin lesions may be difficult to diagnose early because of their highly variable and often seemingly innocuous appearance1-4; it is not uncommon for there to be extensive local spread and/or distant metastases by the time angiosarcoma is diagnosed. Cutaneous angiosarcoma typically affects elderly patients and is more common in men.1-4 It is relatively rare in black individuals.1,3 Classic presentation is an erythematous or violaceous lesion arising on the scalp of an elderly white man.1-4 Cutaneous angiosarcoma has well-documented associations with a number of conditions and factors, including chronic lymphedema, prior radiation therapy, and exposure to chemicals such as thorotrast and vinyl chloride.1-4 In addition, there are several reported cases of malignant transformation to angiosarcoma of otherwise benign vascular lesions such as hemangiomas.5 To date, there is only one reported case of cutaneous angiosarcoma arising in association with scleroderma on the face of a 77-year-old white woman with systemic sclerosis (SSc).6 We report the case of a 40-year-old black man with SSc who developed a cutaneous angiosarcoma in an area of sclerodermatous scalp. back to top


Case Report
A 40-year-old black man with a 5-year history of SSc involving the skin, lungs, and esophagus developed a painful nodule in a sclerodermatous plaque on the scalp (Figure 1). The patient's medical history was remarkable for Raynaud phenomenon, with recurrent digital ulcerations, a restrictive ventilatory defect, chronic dysphagia, and gastroesophageal reflux disease, as well as diffuse thickening and tightening of the skin, all related to his SSc. Serologic tests revealed antinuclear antibodies (titer ≥640) with a homogeneous nucleolar pattern and high levels of anti–Scl-70 antibodies. Anticentromere and anti-DNA antibodies were absent. His only medications were esomeprazole magnesium (40 mg daily) and amlodipine besylate (5 mg daily).

On physical examination, there was a 1.8-cm faintly erythematous nodule with overlying excoriations and crust on the right anterior parietal scalp. The remainder of the physical examination was notable for diffusely tight, firm, shiny skin involving the scalp, face, neck, chest, arms, hands, and groin. There were areas of depigmentation in several of the scleroderma plaques as well as multiple fingertip ulcerations. On initial evaluation, the scalp lesion was diagnosed as a skin abscess not requiring further intervention. It continued to grow and cause discomfort, eventually necessitating surgical excision. Because of its anatomic position and the extremely taut nature of the surrounding sclerodermatous scalp, the mass was excised only partially so that primary closure would be possible. Histologic evaluation of the 2.5X1.5-cm surgical specimen revealed an epithelioid-type high-grade angiosarcoma composed of cells that were positive for CD31 and CD34 (endothelial cell markers) on immunohistochemical stain (Figure 2). A wide excision of the lesion was then performed. Intraoperatively, the tumor was observed to have involved the galea and pericranium, necessitating removal of full-thickness soft tissue and adjacent bone (Figure 3). The scalp excision defect was closed with a split-thickness skin graft.

 Microscopic examination of the excised tissue revealed extensive invasion of the dermis, perineural tissue, and deep skeletal muscle by angiosarcoma. Both circumferential and deep margins of the surgical specimen were involved by tumor. Tumor size was estimated at 9.5 cm. Computed tomographic (CT) scans of the chest, abdomen, and pelvis revealed a moderately dilated esophagus and moderate diffuse, hazy, ground glass pattern radiodensities of the bilateral lung bases consistent with SSc but no lesions suggestive of metastasis. The extensive local tissue involvement by tumor dictated radiation therapy to the area. Treatment was delayed, however, by failure of the skin graft to completely heal. The open wound was subsequently surgically debrided and closed with an allograft. This second graft began to successfully heal, but an enlarging subcutaneous mass at its anterior border soon developed. Results of a biopsy revealed recurrent angiosarcoma. This lesion grew quickly to encompass over half of the patient's forehead, as well as the nasal root, causing severe periorbital edema and conjunctival congestion. Daily radiation therapy totaling 5000 cGy to the upper face and frontal, parietal, and occipital scalp was initiated. Soon after, the patient was hospitalized for methicillin-resistant Staphylococcus aureus bacteremia thought to have originated from a skin infection near the tumor. He also complained of worsening sharp right retroauricular and left hip pains. Results of a punch biopsy of the right posterior auricular scalp revealed recurrent angiosarcoma, and a CT-guided biopsy specimen of the left iliac bone revealed metastatic angiosarcoma. Magnetic resonance imaging of the pelvis and lower extremities showed bone marrow lesions involving the left ischium, left anterior superior iliac spine, and femoral necks of both legs. Palliative radiation therapy to the left iliac bone was initiated for symptom control. Given the extensive metastatic spread, systemic paclitaxel chemotherapy (100 mg/m2 weekly [3 of 4 weeks]) was administered through a central venous port. Soon after completing the first round of chemotherapy, the patient was hospitalized with a polymicrobial infection of his partially healed scalp wound including Klebsiella pneumoniae, Pseudomonas aeruginosa, and group B streptococci. He was treated with levofloxacin (500 mg daily for 10 days). An abdominal CT scan showed that the patient had a lesion in the right posterior inferior lobe of the liver suggestive of metastatic angiosarcoma. Several weeks after discharge, he presented to the emergency department of an outside hospital complaining of worsening dysphagia and purulent material draining from his central venous port. Shortly thereafter, he died, with sepsis as the presumed cause of death. At autopsy, there were multiple large scalp ulcerations extending to bone. The skin was diffusely firm and taut. Serial sectioning of the liver demonstrated a somewhat hemorrhagic-appearing dark red–brown lesion measuring 3 cm in the right posterior lobe, composed microscopically of diffusely infiltrating metastatic angiosarcoma confirmed by CD31 immunostain. Additionally, there were multifocal microabscesses of the heart, lungs, kidneys, spleen, and skin of the face and neck. 


Comment
Systemic sclerosis, or scleroderma, is a chronic systemic disease characterized by widespread fibrosis of the skin and internal organs, vasculopathy, and autoimmunity.7,8 Black individuals are affected more frequently than white individuals and tend to have an earlier age of disease onset, greater tendency for severe disease, and overall worse prognosis.9 Patients with SSc have a 2.6% to 8.7% risk of malignancy in general, with lung cancer and squamous cell carcinoma (arising in affected pulmonary or skin tissue) among the most commonly associated neoplasms.10,11 To our knowledge, we describe the second reported case of SSc-associated angiosarcoma. Systemic sclerosis is thought to arise from altered endothelial cell function and blood vessel reactivity occurring in association with inflammation and autoimmunity. The earliest disease manifestations are generally vasculature related, with most patients developing Raynaud phenomenon before manifesting signs and symptoms of overt sclerosis.7,8 Characteristic nail fold capillaroscopy findings in patients with SSc include enlarged capillaries, busy capillary formations, microhemorrhages, and variable capillary loss.7 Patients with SSc have increased serum and skin levels of vascular endothelial growth factor (VEGF), a key mediator of angiogenesis that induces differentiation, proliferation, and migration of endothelial cells.7 Endothelial cell VEGF receptors are up-regulated in SSc as well. This chronic overexpression of VEGF is thought to account for the chaotic vessel morphology observed on nail fold capillaroscopy.7 We hypothesize that elevated levels of VEGF in sclerodermatous skin may also predispose one to the development of angiosarcoma. Studies have shown that the proliferating cells in angiosarcoma overexpress VEGF messenger RNA, VEGF protein, and VEGF receptors, suggesting that VEGF may spur the development and invasion of neoplasia.12-14 Furthermore, Arbiser et al13 found that overexpression of human VEGF in immortalized endothelial cells was sufficient to convert them from benign hemangiomas to malignant angiosarcomas. Cutaneous angiosarcoma can assume a variety of clinical appearances, including bruiselike lesions, dusky plaques, chronic edema or cellulitis, ulcerated nodules, infectious-appearing lesions, and scarring alopecia.1-4 Tumor tissue usually extends far beyond the apparent borders of the lesion and frequently invades underlying soft tissue and bone. Thus, patients often have advanced disease at the time of diagnosis.1-4 Angiosarcoma prognosis is generally poor, with reported 5-year survival rates ranging from 10% to 35%.1,2 Surgical excision, extended-field radiotherapy, and/or paclitaxel chemotherapy are commonly employed modes of treatment,1,4,15,16 though even with these interventions, local tumor recurrence and distant metastases are common. Importantly, early diagnosis positively correlates with prolonged survival.3,4


Conclusion
We present a case of cutaneous angiosarcoma arising in an area of SSc-affected skin. We suspect that the co-occurrence of these 2 diseases may be related to interconnected underlying pathophysiology. Because early diagnosis can positively impact prognosis, physicians should maintain a high index of clinical suspicion and low threshold for performing a biopsy when suspicious lesions are present on sclerodermatous skin.

 

 

Acknowledgment—We thank Frederick M. Wigley, MD, for his detailed clinic and procedure notes. 

References

  1. Mark RJ, Poen JC, Tran LM, et al. Angiosarcoma: a report of 67 patients and a review of the literature. Cancer. 1996;77:2400-2406.
  2. Morgan MB, Swann M, Somach S, et al. Cutaneous angiosarcoma: a case series with prognostic correlation. J Am Acad Dermatol. 2004;50:867-874.
  3. Holden CA, Spittle MF, Jones EW. Angiosarcoma of the face and scalp, prognosis and treatment. Cancer. 1987;59:1046-1057.
  4. Haustein UF. Angiosarcoma of the face and scalp. Int J Dermatol. 1991;30:851-856.
  5. Rossi S, Fletcher CD. Angiosarcoma arising in hemangioma/vascular malformation: report of four cases and review of the literature. Am J Surg Pathol. 2002;26:1319-1329.
  6. Puizina-Ivic N, Bezic J, Marasovic D, et al. Angiosarcoma arising in sclerodermatous skin. Acta Dermatovenerol Alp Panonica Adriat. 2005;14:20-25.
  7. Distler O, Distler JH, Scheid A, et al. Uncontrolled expression of vascular endothelial growth factor and its receptors leads to insufficient skin angiogenesis in patients with systemic sclerosis. Circ Res. 2004;95: 109-116.
  8. Abraham DJ, Varga J. Scleroderma: from cell and molecular mechanisms to disease models. Trends Immunol. 2005;26:587-595.
  9. Reveille JD. Ethnicity and race and systemic sclerosis: how it affects susceptibility, severity, antibody genetics, and clinical manifestations. Curr Rheumatol Rep. 2003;5:160-167.
  10. Leandro MJ, Isenberg DA. Rheumatic diseases and malignancy—is there an association? Scand J Rheumatol. 2001;30:185-188.
  11. Rosenthal AK, McLaughlin JK, Gridley G, et al. Incidence of cancer among patients with systemic sclerosis. Cancer. 1995;76:910-914.
  12. Amo Y, Masuzawa M, Hamada Y, et al. Serum concentrations of vascular endothelial growth factor in angiosarcomas with and without p53 gene mutation. Acta Derm Venereol. 2002;82:373-374.
  13. Arbiser JL, Larsson H, Claesson-Welsh L, et al. Overexpression of VEGF 121 in immortalized endothelial cells causes conversion to slowly growing angiosarcoma and high level expression of the VEGF receptors VEGFR-1 and VEGFR-2 in vivo. Am J Pathol. 2000;156:1469-1476.
  14. Zietz C, Rössle M, Haas C, et al. MDM-2 oncoprotein overexpression, p53 gene mutation, and VEGF up-regulation in angiosarcomas. Am J Pathol. 1998;153:1425-1433.
  15. Fata F, O'Reilly E, Ilson D, et al. Paclitaxel in the treatment of patients with angiosarcoma of the scalp or face. Cancer. 1999;86:2034-2037.
  16. Skubitz KM, Haddad PA. Paclitaxel and pegylated-liposomal doxorubicin are both active in angiosarcoma. Cancer. 2005;104:361-366.
References

  1. Mark RJ, Poen JC, Tran LM, et al. Angiosarcoma: a report of 67 patients and a review of the literature. Cancer. 1996;77:2400-2406.
  2. Morgan MB, Swann M, Somach S, et al. Cutaneous angiosarcoma: a case series with prognostic correlation. J Am Acad Dermatol. 2004;50:867-874.
  3. Holden CA, Spittle MF, Jones EW. Angiosarcoma of the face and scalp, prognosis and treatment. Cancer. 1987;59:1046-1057.
  4. Haustein UF. Angiosarcoma of the face and scalp. Int J Dermatol. 1991;30:851-856.
  5. Rossi S, Fletcher CD. Angiosarcoma arising in hemangioma/vascular malformation: report of four cases and review of the literature. Am J Surg Pathol. 2002;26:1319-1329.
  6. Puizina-Ivic N, Bezic J, Marasovic D, et al. Angiosarcoma arising in sclerodermatous skin. Acta Dermatovenerol Alp Panonica Adriat. 2005;14:20-25.
  7. Distler O, Distler JH, Scheid A, et al. Uncontrolled expression of vascular endothelial growth factor and its receptors leads to insufficient skin angiogenesis in patients with systemic sclerosis. Circ Res. 2004;95: 109-116.
  8. Abraham DJ, Varga J. Scleroderma: from cell and molecular mechanisms to disease models. Trends Immunol. 2005;26:587-595.
  9. Reveille JD. Ethnicity and race and systemic sclerosis: how it affects susceptibility, severity, antibody genetics, and clinical manifestations. Curr Rheumatol Rep. 2003;5:160-167.
  10. Leandro MJ, Isenberg DA. Rheumatic diseases and malignancy—is there an association? Scand J Rheumatol. 2001;30:185-188.
  11. Rosenthal AK, McLaughlin JK, Gridley G, et al. Incidence of cancer among patients with systemic sclerosis. Cancer. 1995;76:910-914.
  12. Amo Y, Masuzawa M, Hamada Y, et al. Serum concentrations of vascular endothelial growth factor in angiosarcomas with and without p53 gene mutation. Acta Derm Venereol. 2002;82:373-374.
  13. Arbiser JL, Larsson H, Claesson-Welsh L, et al. Overexpression of VEGF 121 in immortalized endothelial cells causes conversion to slowly growing angiosarcoma and high level expression of the VEGF receptors VEGFR-1 and VEGFR-2 in vivo. Am J Pathol. 2000;156:1469-1476.
  14. Zietz C, Rössle M, Haas C, et al. MDM-2 oncoprotein overexpression, p53 gene mutation, and VEGF up-regulation in angiosarcomas. Am J Pathol. 1998;153:1425-1433.
  15. Fata F, O'Reilly E, Ilson D, et al. Paclitaxel in the treatment of patients with angiosarcoma of the scalp or face. Cancer. 1999;86:2034-2037.
  16. Skubitz KM, Haddad PA. Paclitaxel and pegylated-liposomal doxorubicin are both active in angiosarcoma. Cancer. 2005;104:361-366.
Issue
Cutis - 81(6)
Issue
Cutis - 81(6)
Page Number
468-471
Page Number
468-471
Publications
Publications
Topics
Article Type
Display Headline
Angiosarcoma Complicating Systemic Sclerosis: A Case Report
Display Headline
Angiosarcoma Complicating Systemic Sclerosis: A Case Report
Article Source

PURLs Copyright

Inside the Article

Article PDF Media

Combined Use of a Rotation Flap and High-Viscosity 2-Octyl Cyanoacrylate for Reconstruction of a Facial Defect After Excision of a Nodular Basal Cell Carcinoma by Mohs Micrographic Surgery

Article Type
Changed
Display Headline
Combined Use of a Rotation Flap and High-Viscosity 2-Octyl Cyanoacrylate for Reconstruction of a Facial Defect After Excision of a Nodular Basal Cell Carcinoma by Mohs Micrographic Surgery

Article PDF
Author and Disclosure Information

Nouri K, Martins A, Vejjabhinanta V

Issue
Cutis - 81(5)
Publications
Topics
Page Number
264-266
Sections
Author and Disclosure Information

Nouri K, Martins A, Vejjabhinanta V

Author and Disclosure Information

Nouri K, Martins A, Vejjabhinanta V

Article PDF
Article PDF

Issue
Cutis - 81(5)
Issue
Cutis - 81(5)
Page Number
264-266
Page Number
264-266
Publications
Publications
Topics
Article Type
Display Headline
Combined Use of a Rotation Flap and High-Viscosity 2-Octyl Cyanoacrylate for Reconstruction of a Facial Defect After Excision of a Nodular Basal Cell Carcinoma by Mohs Micrographic Surgery
Display Headline
Combined Use of a Rotation Flap and High-Viscosity 2-Octyl Cyanoacrylate for Reconstruction of a Facial Defect After Excision of a Nodular Basal Cell Carcinoma by Mohs Micrographic Surgery
Sections
Article Source

Citation Override
Originally published in Cosmetic Dermatology
PURLs Copyright

Inside the Article

Article PDF Media

Primary Cutaneous Adenoid Cystic Carcinoma: A Case Report and Review of the Literature

Article Type
Changed
Display Headline
Primary Cutaneous Adenoid Cystic Carcinoma: A Case Report and Review of the Literature

Article PDF
Author and Disclosure Information

Barnes J, Garcia C

Issue
Cutis - 81(3)
Publications
Topics
Page Number
243-246
Author and Disclosure Information

Barnes J, Garcia C

Author and Disclosure Information

Barnes J, Garcia C

Article PDF
Article PDF

Issue
Cutis - 81(3)
Issue
Cutis - 81(3)
Page Number
243-246
Page Number
243-246
Publications
Publications
Topics
Article Type
Display Headline
Primary Cutaneous Adenoid Cystic Carcinoma: A Case Report and Review of the Literature
Display Headline
Primary Cutaneous Adenoid Cystic Carcinoma: A Case Report and Review of the Literature
Article Source

PURLs Copyright

Inside the Article

Article PDF Media

Cutaneous Metastasis of Invasive Ductal Carcinoma of the Breast to an Infusaport Site

Article Type
Changed
Display Headline
Cutaneous Metastasis of Invasive Ductal Carcinoma of the Breast to an Infusaport Site

Article PDF
Author and Disclosure Information

Lehman JS, Benacci JC

Issue
Cutis - 81(3)
Publications
Topics
Page Number
223-226
Author and Disclosure Information

Lehman JS, Benacci JC

Author and Disclosure Information

Lehman JS, Benacci JC

Article PDF
Article PDF

Issue
Cutis - 81(3)
Issue
Cutis - 81(3)
Page Number
223-226
Page Number
223-226
Publications
Publications
Topics
Article Type
Display Headline
Cutaneous Metastasis of Invasive Ductal Carcinoma of the Breast to an Infusaport Site
Display Headline
Cutaneous Metastasis of Invasive Ductal Carcinoma of the Breast to an Infusaport Site
Article Source

PURLs Copyright

Inside the Article

Article PDF Media

Primary Cutaneous Mucinous Carcinoma: Case Report and Review of the Literature

Article Type
Changed
Display Headline
Primary Cutaneous Mucinous Carcinoma: Case Report and Review of the Literature

Article PDF
Author and Disclosure Information

Bhambri S, Del Rosso JQ, Mobini N, Michaels B

Issue
Cutis - 81(2)
Publications
Topics
Page Number
86-88
Legacy Keywords
Primary Cutaneous Mucinous Carcinoma, PCMC, secondary Cutaneous Mucinous Carcinoma, malignant neoplasm, sweat duct, eyelid, sweat glands, Bhambri S, Del Rosso JQ, Mobini N, Michaels BPrimary Cutaneous Mucinous Carcinoma, PCMC, secondary Cutaneous Mucinous Carcinoma, malignant neoplasm, sweat duct, eyelid, sweat glands, Bhambri S, Del Rosso JQ, Mobini N, Michaels B
Sections
Author and Disclosure Information

Bhambri S, Del Rosso JQ, Mobini N, Michaels B

Author and Disclosure Information

Bhambri S, Del Rosso JQ, Mobini N, Michaels B

Article PDF
Article PDF

Issue
Cutis - 81(2)
Issue
Cutis - 81(2)
Page Number
86-88
Page Number
86-88
Publications
Publications
Topics
Article Type
Display Headline
Primary Cutaneous Mucinous Carcinoma: Case Report and Review of the Literature
Display Headline
Primary Cutaneous Mucinous Carcinoma: Case Report and Review of the Literature
Legacy Keywords
Primary Cutaneous Mucinous Carcinoma, PCMC, secondary Cutaneous Mucinous Carcinoma, malignant neoplasm, sweat duct, eyelid, sweat glands, Bhambri S, Del Rosso JQ, Mobini N, Michaels BPrimary Cutaneous Mucinous Carcinoma, PCMC, secondary Cutaneous Mucinous Carcinoma, malignant neoplasm, sweat duct, eyelid, sweat glands, Bhambri S, Del Rosso JQ, Mobini N, Michaels B
Legacy Keywords
Primary Cutaneous Mucinous Carcinoma, PCMC, secondary Cutaneous Mucinous Carcinoma, malignant neoplasm, sweat duct, eyelid, sweat glands, Bhambri S, Del Rosso JQ, Mobini N, Michaels BPrimary Cutaneous Mucinous Carcinoma, PCMC, secondary Cutaneous Mucinous Carcinoma, malignant neoplasm, sweat duct, eyelid, sweat glands, Bhambri S, Del Rosso JQ, Mobini N, Michaels B
Sections
Article Source

Citation Override
Originally published in Cosmetic Dermatology
PURLs Copyright

Inside the Article

Article PDF Media

Leukemia Cutis Masquerading as Vitiligo

Article Type
Changed
Display Headline
Leukemia Cutis Masquerading as Vitiligo

Article PDF
Author and Disclosure Information

Newman MD, Milgraum S

Issue
Cutis - 81(2)
Publications
Topics
Page Number
163-165
Author and Disclosure Information

Newman MD, Milgraum S

Author and Disclosure Information

Newman MD, Milgraum S

Article PDF
Article PDF

Issue
Cutis - 81(2)
Issue
Cutis - 81(2)
Page Number
163-165
Page Number
163-165
Publications
Publications
Topics
Article Type
Display Headline
Leukemia Cutis Masquerading as Vitiligo
Display Headline
Leukemia Cutis Masquerading as Vitiligo
Article Source

PURLs Copyright

Inside the Article

Article PDF Media